healthcare
Johnson & Johnson commits $15m to Vivo's healthcare fund
Johnson & Johnson Innovation (JJDC) - the venture capital arm of the eponymous healthcare and consumer goods multinational - has committed to $15 million to Vivo Capital's latest US and China-focused healthcare fund.
PE-backed Meinian Onehealth to list via reverse merger
Meinian Onehealth Healthcare Group, the largest private provider of preventive healthcare check-up services in China and a portfolio company of The Carlyle Group among others, plans to list in Shenzhen through a reverse merger with Jiangsu Sanyou Group.
Vivo boosts fund for cross-border play
Healthcare-focused Vivo Capital has attracted increasing attention from LPs for its hybrid focus on the US and China. As testament to this, its latest fund - Vivo Capital Fund VIII - closed at $750 million after nine months in the market, with demand...
INCJ consortium invests $21m in Japan stem cell start-up
Megakaryon, a Japan-based stem cell technology developer, has raised JPY2.54 billion ($21.2 million) from a consortium of investors including existing backers Innovation Network Corporation of Japan (INCJ), Mitsubishi UFJ Capital, SMBC Venture Capital...
Vivo closes latest Sino-US healthcare fund at $750m
US-based Vivo Capital has closed its eighth fund at $750 million. It will invest in healthcare companies in the US and China.
HK’s Nest appoints ex-Intel executive to set up accelerator franchise
Hong Kong-based seed investor Nest has appointed Peter Dingle, formerly of Intel Corporation, to lead its newly-established Branded Accelerators program.
Indonesia middle market: Slow-burn story
Indonesia’s middle market is a proxy for the robust services sector, but it is difficult for investors to penetrate and deal flow has been slow in recent years. Are we are about to see more?
Korea's SMBA, IDG form $91m VC fund
IDG Capital Partners and South Korea's Small and Medium Business Administration have agreed to form a KRW100 billion ($91 million) VC fund that will help Korean businesses enter the China market.
IFC leads $10m round for India eye hospital chain
International Finance Corporation (IFC) has invested $5.5 million in Indian eye clinic chain Eye-Q Vision, leading a round of financing for the company worth $10 million.
Biopharma venture raises $7.3m from Korean investors
Korean healthcare-focused VC firm InterVest and tech-focused E&Investment have together invested $7.28 million in G-treeBNT, a Seoul-based diversified bio pharmaceutical business.
Chinese VC-backed hospital chain files for Hong Kong IPO
Pengai Hospital Management Group, a Chinese cosmetic surgery chain backed by CMHJ Partners, IDG Capital and TDR Capital, has filed for a Hong Kong IPO.
Qiming leads Series A for China medical research, translation provider
Qiming Venture Partners has led a Series A round of funding for MedSci, a Chinese clinical research and academic translation services online platform.
Ally Bridge participates in $57m round for US biotech firm
Healthcare-focused GP Ally Bridge has participated in a $57 million round of funding for EndoChoice, a US-based endoscopic imaging specialist, with a view to helping the company to expand in China.
JD-backed China Well Lead raises $61m in Shanghai IPO
Well Lead Medical, a Chinese medical devices manufacturer backed by JD Capital, has raised RMB385 million ($61 million) through an IPO in Shanghai.
Japan's INCJ joins acquisition of US biopharma firm
The government-backed Innovation Network corporation of Japan (INCJ), life sciences company JSR Corporation, and pharmaceutical research firm CMIC Holdings have together purchased US-based KBI BioPharma for an undisclosed sum.
China’s online drugstore 7LK raises $48m from VCs
Chinese online drugstore 7LK.com has raised RMB300 million ($48 million) in a Series A round of funding from Govtor Capital, Grand Yangtze Capital and TusPark Ventures.
TPG buys $146m stake in India’s Manipal Hospitals
TPG Capital has paid INR9 billion ($146 million) for a significant minority stake in healthcare services provider Manipal Health Enterprises (MHE).
Navis agrees Domestic Group medical equipment unit carve-out
Malaysia-based GP Navis Capital Partners has agreed to buy Domestic Medical Division (DMD), the cold chain medical equipment unit of Sweden's Domestic Group. The financial terms of the deal were not disclosed.
Australia VC: Policy permutations
Plans to reinstate tax breaks for Australian start-ups that issue share options to staff rather than pay sizeable salaries has cheered VC investors. They are generally positive about the government role in fostering innovation
Israeli Rainbow Medical raises $25m from Chinese investors
Rainbow Medical, an Israeli medical investment firm, has raised $25 million from a group of Chinese investors including Ping An Insurance and telecom giant ZTE Corporation,financial company Yongjin Group and undisclosed Chinese venture capital funds.
Sequoia, Matrix commit $30m to Indian doctor search site
Sequoia Capital India and Matrix Partners have invested $30 million in a Series B round of funding for Practo Technologies, an Indian start-up that provides a search portal matching patients and doctors.
Australian biotech start-up raises $20m Series B round
Vaxxas, an Australian biotechnology start-up developing a novel vaccination platform, has raised a A$25 million ($20 million) Series B round of funding from a group of new and existing investors led by OneVentures.
SAIF, Innovation Works back China healthcare start-up
SAIF Partners and Innovation Works have provided a Series A round of funding for Beijing Dnurse Technology, a Chinese company that develops technology used to track sugar levels in the body.
Taiwan’s MasterLink Securities launches VC units in Tianjin
MasterLink Securities, the fourth-largest brokerage firm in Taiwan, has won regulatory approval to launch two venture capital investment units in mainland China.